OTCQX
MVMDF

Mountain Valley MD Holdings Inc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Mountain Valley MD Holdings Inc Stock Price

Vitals

Today's Low:
$0.0316
Today's High:
$0.0353
Open Price:
$0.0353
52W Low:
$0.017
52W High:
$0.0728
Prev. Close:
$0.0356
Volume:
1100

Company Statistics

Market Cap.:
$13.68 million
Book Value:
0.049
Revenue TTM:
$110000
Operating Margin TTM:
0%
Gross Profit TTM:
$-2139000
Profit Margin:
0%
Return on Assets TTM:
-16.51%
Return on Equity TTM:
-36.28%

Company Profile

Mountain Valley MD Holdings Inc had its IPO on under the ticker symbol MVMDF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Mountain Valley MD Holdings Inc has a staff strength of 0 employees.

Stock update

Shares of Mountain Valley MD Holdings Inc opened at $0.04 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.03 - $0.04, and closed at $0.03.

This is a -5.06% slip from the previous day's closing price.

A total volume of 1,100 shares were traded at the close of the day’s session.

In the last one week, shares of Mountain Valley MD Holdings Inc have slipped by -6.11%.

Mountain Valley MD Holdings Inc's Key Ratios

Mountain Valley MD Holdings Inc has a market cap of $13.68 million, indicating a price to book ratio of 0.5104 and a price to sales ratio of 84.027.

In the last 12-months Mountain Valley MD Holdings Inc’s revenue was $110000 with a gross profit of $-2139000 and an EBITDA of $-5106000. The EBITDA ratio measures Mountain Valley MD Holdings Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Mountain Valley MD Holdings Inc’s operating margin was 0% while its return on assets stood at -16.51% with a return of equity of -36.28%.

In Q1, Mountain Valley MD Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Mountain Valley MD Holdings Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.02 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Mountain Valley MD Holdings Inc’s profitability.

Mountain Valley MD Holdings Inc stock is trading at a EV to sales ratio of 4.6249 and a EV to EBITDA ratio of 0.1165. Its price to sales ratio in the trailing 12-months stood at 84.027.

Mountain Valley MD Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$16.77 million
Total Liabilities
$591000.00
Operating Cash Flow
$0
Capital Expenditure
$40000
Dividend Payout Ratio
0%

Mountain Valley MD Holdings Inc ended 2024 with $16.77 million in total assets and $0 in total liabilities. Its intangible assets were valued at $16.77 million while shareholder equity stood at $16.18 million.

Mountain Valley MD Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $591000.00 in other current liabilities, in common stock, $-44119000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $9.71 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Mountain Valley MD Holdings Inc’s total current assets stands at $10.87 million while long-term investments were $1.55 million and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $336000.00 and inventory worth $0.

In 2024, Mountain Valley MD Holdings Inc's operating cash flow was $0 while its capital expenditure stood at $40000.

Comparatively, Mountain Valley MD Holdings Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.03
52-Week High
$0.0728
52-Week Low
$0.017
Analyst Target Price
$

Mountain Valley MD Holdings Inc stock is currently trading at $0.03 per share. It touched a 52-week high of $0.0728 and a 52-week low of $0.0728. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.03 and 200-day moving average was $0.04 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 106.3% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Mountain Valley MD Holdings Inc

The stock symbol (also called stock or share ticker) of Mountain Valley MD Holdings Inc is MVMDF

The IPO of Mountain Valley MD Holdings Inc took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$1613.4
-59.5
-3.56%
$4.67
0.17
+3.78%
$1510.35
-64.2
-4.08%
$7.47
-0.74
-9.01%
$85.21
-6.69
-7.28%
$1.11
-0.02
-1.77%
$1.97
0.05
+2.6%
$22.84
-1.31
-5.42%
$2.11
-0.02
-0.94%
$40.05
-0.94
-2.29%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company. It engages in the implementation and licensing of its technologies and formulations to deliver molecules for human and husbandry animal applications, including the development of products for pain management, weight loss, energy, focus, sleep, anxiety, and others. The company offers Quicksome oral drug formulation and delivery technologies; Quicksol solubility formulation technology; and dose sparing adjuvant. In addition, it provides licensed Agrarius, an agricultural plant signalling technology. The company is headquartered in Concord, Canada.

Address

260 Edgeley Boulevard, Concord, ON, Canada, L4K 3Y4